Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Photobiomodulation Therapy in Hypertension Management-Evidence from a Systematic Review and Meta-Analysis

AI-generated summary

The authors systematically reviewed four randomized clinical trials and five animal experiments on photobiomodulation for hypertension. They report that light treatments were associated with lower blood pressure and heart rate in trials and lower blood pressure with higher nitric oxide in animals. The authors note the certainty of evidence is very low and the risk of bias is high or unclear.

Who or what was studied
Hypertensive patients and hypertensive experimental animals
Limits stated in the abstract
The abstract states very low certainty of evidence, high risk of bias in the trials, unclear risk of bias in the animal studies, and a need for more rigorous studies.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Hypertensive patients have difficulties in controlling blood pressure (BP), resulting in high mortality rates. There is a growing number of lab and human studies investigating the effects of photobiomodulation (PBM) therapy on hypertension. This motivated the current work to systematically assess existing literature and group evidence on the utility of PBM in BP management.

Methods

A systematic review with meta-analysis was performed on randomized clinical trials (RCTs) and experimental animal studies assessing PBM treatments in hypertensive patients/animals. Five primary databases were assessed by two reviewers. Descriptive and quantitative analyses were performed separately for clinical and experimental studies.

Results

A total of 197 articles were screened that identified four RCTs and five experimental studies for final inclusion. The clinical trials noted that PBM treatments reduced systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR), but with very low certainty. Experimental lab studies corroborated that PBM treatments reduced SBP, DBP, and mean arterial pressure (MAP) while increasing nitric oxide levels, again with very low certainty. Overall, RCTs had a high risk of bias, and experimental studies had an unclear risk of bias.

Conclusions

PBM treatments have the potential to be an adjunct therapy for the treatment of hypertension, with studies showing a possible reduction in SBP, DBP, MAP, and HR, but the evidence is of very low certainty, coming from RCTs with a high risk of bias and experimental studies with an unclear risk of bias. The current evidence needs to be significantly improved with rigorous, well-designed experimental and clinical studies.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Systematic review, Meta-analysis, Photobiomodulation therapy, Risk of bias, Nitric oxide. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies